Correlation Between Regional Brain Volume and Response to Donepezil Treatment in AD Patients

Trial Profile

Correlation Between Regional Brain Volume and Response to Donepezil Treatment in AD Patients

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 19 Nov 2013

At a glance

  • Drugs Donepezil (Primary)
  • Indications Alzheimer's disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Jan 2009 Status changed from recruiting to discontinued.
    • 08 Jan 2009 Planned end date changed from 1 Aug 2008 to 1 Nov 2008.
    • 08 Jan 2009 Planned number of patients changed from 80 to 40.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top